Trends of survival in patients with multiple myeloma in Japan: a multicenter retrospective collaborative study of the Japanese Society of Myeloma

被引：53

作者：

Ozaki, S. ^{[1
]}

Handa, H. ^{[2
]}

Saitoh, T. ^{[3
]}

Murakami, H. ^{[3
]}

Itagaki, M. ^{[4
]}

Asaoku, H. ^{[4
]}

Suzuki, K. ^{[5
]}

Isoda, A. ^{[6
]}

Matsumoto, M. ^{[6
]}

Sawamura, M. ^{[6
]}

Konishi, J. ^{[7
]}

Sunami, K. ^{[7
]}

Takezako, N. ^{[8
]}

Hagiwara, S. ^{[9
]}

Kuroda, Y. ^{[10
]}

Chou, T. ^{[11
]}

Nagura, E. ^{[12
]}

Shimizu, K. ^{[13
]}

机构：

[1] Tokushima Prefectural Cent Hosp, Dept Hematol, Tokushima, Japan

[2] Gunma Univ, Dept Hematol, Maebashi, Gunma 371, Japan

[3] Gunma Univ, Grad Sch Hlth Sci, Dept Lab Sci, Maebashi, Gunma 371, Japan

[4] Hiroshima Red Cross Hosp, Dept Hematol, Hiroshima, Japan

[5] Japanese Red Cross Med Ctr, Dept Hematol, Tokyo, Japan

[6] Natl Hosp Org, Nishigunma Natl Hosp, Dept Hematol, Shibukawa, Japan

[7] Natl Hosp Org, Okayama Med Ctr, Dept Hematol, Okayama, Japan

[8] Natl Hosp Org, Disaster Med Ctr, Div Hematol, Tokyo, Japan

[9] Natl Ctr Global Hlth & Med, Dept Hematol, Tokyo, Japan

[10] Hiroshima Univ Hosp, Dept Hematol, Hiroshima, Japan

[11] Niigata Canc Ctr Hosp, Dept Internal Med, Niigata, Japan

[12] Chutoen Gen Med Ctr, Dept Hematol, Kakegawa, Japan

[13] Tokai Cent Hosp, Dept Hematol, Kakamigahara, Japan

来源：

BLOOD CANCER JOURNAL | 2015年 / 5卷

关键词：

INTERNATIONAL STAGING SYSTEM;

D O I：

10.1038/bcj.2015.79

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：e349 / e349

页数：4

共 50 条

[1] Trends of survival in patients with multiple myeloma in Japan: a multicenter retrospective collaborative study of the Japanese Society of Myeloma
S Ozaki
H Handa
T Saitoh
H Murakami
M Itagaki
H Asaoku
K Suzuki
A Isoda
M Matsumoto
M Sawamura
J Konishi
K Sunami
N Takezako
S Hagiwara
Y Kuroda
T Chou
E Nagura
K Shimizu
Blood Cancer Journal, 2015, 5 : e349 - e349
[2] Survival of Multiple Myeloma Patients in the Era of Novel Agents and Autologous Stem Cell Transplantation: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma
Ozaki, Shuji
Handa, Hiroshi
Saitoh, Takayuki
Murakami, Hirokazu
Itagaki, Mitsuhiro
Asaoku, Hideki
Suzuki, Kenshi
Isoda, Atsushi
Sawamura, Morio
Konishi, Jun
Sunami, Kazutaka
Takezako, Naoki
Hagiwara, Shotaro
Kuroda, Yoshiaki
Chou, Takaaki
Shibata, Eiko
Shimizu, Kazuyuki
Nagura, Eiichi
BLOOD, 2014, 124 (21)
[3] Impact of Continuous and Maintenance Therapy on Survival Outcome in Patients with Newly Diagnosed Multiple Myeloma: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma
Ozaki, Shuji
Handa, Hiroshi
Saitoh, Takayuki
Sunami, Kazutaka
Ishida, Tadao
Suzuki, Kenshi
Narita, Tomoko
Iida, Shinsuke
Nakamura, Yuichi
Suzuki, Kazuhito
Nishimura, Noriko
Murakami, Hirokazu
Shimizu, Kazuyuki
BLOOD, 2019, 134
[4] A Revised International Staging System of Multiple Myeloma in the Era of Novel Agents and Autologous Stem Cell Transplantation in Japan: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma
Ozaki, Shuji
Saitoh, Takayuki
Handa, Hiroshi
Murakami, Hirokazu
Suzuki, Kenshi
Takezako, Naoki
Konishi, Jun
Sunami, Kazutaka
Kuroda, Yoshiaki
Itagaki, Mitsuhiro
Asaoku, Hideki
Nagura, Eiichi
Shimizu, Kazuyuki
BLOOD, 2015, 126 (23)
[5] Novel Agents and Autologous Stem Cell Transplantation Improve Survival of Multiple Myeloma Patients with Ages 65-70 Years: A Multicenter Retrospective Collaborative Study Between Japanese Society of Myeloma and European Myeloma Network
Ozaki, Shuji
Harada, Takeshi
Saitoh, Takayuki
Shimazaki, Chihiro
Itagaki, Mitsuhiro
Asaoku, Hideki
Kuroda, Yoshiaki
Chou, Takaaki
Yoshiki, Yumiko
Suzuki, Kenshi
Murakami, Hirokazu
Hayashi, Kunihiko
Palumbo, Antonio
Shimizu, Kazuyuki
BLOOD, 2012, 120 (21)
[6] Propensity-score matched analysis of the efficacy of maintenance/continuous therapy in newly diagnosed patients with multiple myeloma: a multicenter retrospective collaborative study of the Japanese Society of Myeloma
Shuji Ozaki
Hiroshi Handa
Hiromi Koiso
Takayuki Saitoh
Kazutaka Sunami
Tadao Ishida
Kenshi Suzuki
Tomoko Narita
Shinsuke Iida
Yuichi Nakamura
Kazuhito Suzuki
Noriko Nishimura
Hirokazu Murakami
Kazuyuki Shimizu
Journal of Cancer Research and Clinical Oncology, 2022, 148 : 191 - 203
[7] Propensity-score matched analysis of the efficacy of maintenance/continuous therapy in newly diagnosed patients with multiple myeloma: a multicenter retrospective collaborative study of the Japanese Society of Myeloma
Ozaki, Shuji
Handa, Hiroshi
Koiso, Hiromi
Saitoh, Takayuki
Sunami, Kazutaka
Ishida, Tadao
Suzuki, Kenshi
Narita, Tomoko
Iida, Shinsuke
Nakamura, Yuichi
Suzuki, Kazuhito
Nishimura, Noriko
Murakami, Hirokazu
Shimizu, Kazuyuki
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (01) : 191 - 203
[8] A New Prognostic Scoring System for Multiple Myeloma in the Era of Novel Agents and Autologous Stem Cell Transplantation: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma
Ozaki, Shuji
Saitoh, Takayuki
Handa, Hiroshi
Suzuki, Kenshi
Takezako, Naoki
Sunami, Kazutaka
Kuroda, Yoshiaki
Itagaki, Mitsuhiro
Asaoku, Hideki
Nagura, Eiichi
Kazuyuki, Shimizu
Murakami, Hirokazu
BLOOD, 2016, 128 (22)
[9] Survival rate of multiple myeloma patients in Indonesia: A retrospective study in multiple myeloma at a single institution
Andriandi
Kamal, Achmad Fauzi
ANNALS OF MEDICINE AND SURGERY, 2019, 41 : 11 - 15
[10] Impact of Dialysis Dependence on Survival for Multiple Myeloma Patients with Renal Impairment: A Multicenter Retrospective Study in China
Jian, Yuan
Zhou, Huixing
Xie, Weiwei
Ren, Yuan
Zhang, Zhiyao
Yang, Guangzhong
Geng, Chuanying
Jia, Jing
Chen, Wenming
Li, Jian
Huang, Wenrong
Cen, Xinan
Gao, Wen
BLOOD, 2022, 140 : 12635 - 12636

← 1 2 3 4 5 →